Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| CEO | | 254.2K | $13.54M | - |
| CEO | Kulkarni Samarth | 224.2K | $11.94M | - |
| Other | | 83.4K | $4.44M | - |
| ? | George Simeon | 69.7K | $3.71M | - |
| CFO | Prasad Raju | 30.1K | $1.60M | -29,700 |
Transactions
50 transactions · page 7
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2018-12-24 | Vertex Pharmaceuticals (Europe) Ltd | 10% Owner | Buy | 90,742 | $24.08 | $2,184,960.17 | +0.4% | → |
| 2018-12-18 | EMSTER KURT VON | Director | Sell | 72,934 | $29.85 | $2,176,898.24 | -3.0% | → |
| 2018-11-21 | CELGENE CORP /DE/ | 10% Owner | Sell | 80,000 | $19.25 | $1,540,000.00 | -1.9% | → |
| 2018-07-05 | CAGNONI PABLO J | Director | Sale+OE | 7,500 | $62.00 | $465,000.00 | -100% | → |
| 2018-06-05 | EMSTER KURT VON | Director | Sell | 920 | $12.51 | $11,509.20 | -4.8% | → |
| 2018-06-01 | Kulkarni Samarth | Chief Executive Officer | Sale+OE | 15,000 | $69.36 | $1,040,400.00 | -4.7% | → |
| 2018-05-17 | Novak Rodger | President | Sale+OE | 75,000 | $60.00 | $4,500,000.00 | -6.1% | → |
| 2018-05-15 | Bolzon Bradley J PhD | Director | Sell | 44,000 | $57.99 | $2,551,440.00 | -3.3% | → |
| 2018-05-15 | Woiwode Thomas | Director | Sell | 44,000 | $57.99 | $2,551,440.00 | -3.3% | → |
| 2018-05-14 | EMSTER KURT VON | Director | Sell | 650,000 | $54.39 | $35,352,455.99 | -4.7% | → |
| 2018-05-08 | Woiwode Thomas | Director | Sell | 121,362 | $50.39 | $6,115,872.59 | -4.3% | → |
| 2018-05-08 | Bolzon Bradley J PhD | Director | Sell | 128,950 | $50.39 | $6,497,892.30 | -4.4% | → |
| 2018-04-30 | Woiwode Thomas | Director | Sell | 30,566 | $50.29 | $1,537,137.92 | -2.0% | → |
| 2018-04-30 | Bolzon Bradley J PhD | Director | Sell | 26,860 | $50.29 | $1,350,789.40 | -2.0% | → |